Literature DB >> 8038315

Infection with Mycobacterium malmoense in Sweden: report of 221 cases.

B Henriques1, S E Hoffner, B Petrini, I Juhlin, P Wåhlén, G Källenius.   

Abstract

Mycobacterium malmoense was first described in 1977 and today is second only to the Mycobacterium avium complex as a cause of atypical mycobacterial infection in Sweden. We retrospectively studied the records of 221 patients from whom M. malmoense was isolated during 1968-1989. M. malmoense was recovered from the respiratory tract of 171 patients (170 adults and one child) and from cervical lymph nodes of 36 patients (35 children and one adult). In addition, the organism was isolated from the urine of six patients, one of whom had disseminated disease and two of whom had abscesses caused by M. malmoense. A majority of the patients with pulmonary infection as well as the patient with disseminated disease had other underlying diseases.

Entities:  

Mesh:

Year:  1994        PMID: 8038315     DOI: 10.1093/clinids/18.4.596

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  24 in total

1.  Rapid immunochromatographic assay for diagnosis of tuberculosis: antibodies detected may not be specific.

Authors:  R Freeman; J Magee; A Barratt; J Wheeler; M Steward; M Lee; N Piggott
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

2.  Management of opportunist mycobacterial infections: Joint Tuberculosis Committee Guidelines 1999. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society.

Authors: 
Journal:  Thorax       Date:  2000-03       Impact factor: 9.139

Review 3.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

4.  Mycobacterium malmoense in Italy: the modern Norman invasion?

Authors:  E Tortoli; C Piersimoni; A Bartoloni; C Burrini; A P Callegaro; G Caroli; D Colombrita; A Goglio; A Mantella; C P Tosi; M T Simonetti
Journal:  Eur J Epidemiol       Date:  1997-04       Impact factor: 8.082

Review 5.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

6.  Performance assessment of new multiplex probe assay for identification of mycobacteria.

Authors:  E Tortoli; A Nanetti; C Piersimoni; P Cichero; C Farina; G Mucignat; C Scarparo; L Bartolini; R Valentini; D Nista; G Gesu; C P Tosi; M Crovatto; G Brusarosco
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

7.  Cervical abscess in an immunocompetent patient with Mycobacterium malmoense pulmonary disease.

Authors:  Joao N Duarte; Nuno Marques; Leonor Barroso; Isabel Ramos; Rosa Sá; David Sanz; Artur Ferreira; Saraiva da Cunha
Journal:  Oral Maxillofac Surg       Date:  2011-11-05

8.  Mycobacterium malmoense-specific nested PCR based on a conserved sequence detected in random amplified polymorphic DNA fingerprints.

Authors:  J Kauppinen; R Mäntyjärvi; M L Katila
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

9.  Mycobacterium malmoense lymphadenitis in Spain: first two cases in immunocompetent patients.

Authors:  A I López-Calleja; M A Lezcano; S Samper; F de Juan; M J Revillo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-06-26       Impact factor: 3.267

Review 10.  Pulmonary infections caused by less frequently encountered slow-growing environmental mycobacteria.

Authors:  S E Hoffner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.